XHS Quote, Financials, Valuation and Earnings

Range Cancer Therapeutics ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Range Cancer Therapeutics ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Range Cancer Therapeutics ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Range Cancer Therapeutics ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Range Cancer Therapeutics ETF.

SPDR S&P Health Care Services ETF has a beta of 1.030, which suggesting that the stock is 2.997% more volatile than S&P 500. In comparison Range Cancer Therapeutics ETF has a beta of 0.929, suggesting its less volatile than the S&P 500 by 7.096%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. Range Cancer Therapeutics ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Range Cancer Therapeutics ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Range Cancer Therapeutics ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Range Cancer Therapeutics ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Range Cancer Therapeutics ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Range Cancer Therapeutics ETF. Usually stocks with elevated PS ratios are considered overvalued.

First Trust Nasdaq Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat First Trust Nasdaq Pharmaceuticals ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than First Trust Nasdaq Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than First Trust Nasdaq Pharmaceuticals ETF.

SPDR S&P Health Care Services ETF has a beta of 1.030, which suggesting that the stock is 2.997% more volatile than S&P 500. In comparison First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.633%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. First Trust Nasdaq Pharmaceuticals ETF offers a yield of 1.65% to investors and pays a quarterly dividend of $0.13 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. First Trust Nasdaq Pharmaceuticals ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than First Trust Nasdaq Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than First Trust Nasdaq Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while First Trust Nasdaq Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for First Trust Nasdaq Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

Simplify Propel Opportunities ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Simplify Propel Opportunities ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Simplify Propel Opportunities ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Simplify Propel Opportunities ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Simplify Propel Opportunities ETF.

SPDR S&P Health Care Services ETF has a beta of 1.030, which suggesting that the stock is 2.997% more volatile than S&P 500. In comparison Simplify Propel Opportunities ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. Simplify Propel Opportunities ETF offers a yield of 20.48% to investors and pays a quarterly dividend of $0.68 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Simplify Propel Opportunities ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Simplify Propel Opportunities ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Simplify Propel Opportunities ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Simplify Propel Opportunities ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Simplify Propel Opportunities ETF. Usually stocks with elevated PS ratios are considered overvalued.

SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.

SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than SPDR S&P Pharmaceuticals ETF.

SPDR S&P Health Care Services ETF has a beta of 1.030, which suggesting that the stock is 2.997% more volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.757, suggesting its less volatile than the S&P 500 by 24.326%.

SPDR S&P Health Care Services ETF has a quarterly dividend of $0.08 per share corresponding to a yield of 0.36%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.58% to investors and pays a quarterly dividend of $0.15 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.